Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Polycystic Ovary Syndrome × cetrorelix × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 11 Chorionic Gonadotropin 5 drospirenone and ethinyl estradiol combination 4 Progesterone 4 Flutamide 4 Clomiphene 4 Cholecalciferol 4 follitropin alfa 3 Sugars 3 Pioglitazone 3 Medroxyprogesterone Acetate 3 Glycoprotein Hormones, alpha Subunit 3 Estrogens 3 Testosterone 2 Resistance Training 2 Raloxifene Hydrochloride 2 Ovidrel 2 Liraglutide 2 Leuprolide 2 Letrozole 2 Exenatide 2 Estradiol 2 Contraceptives, Oral 2 Continuous Positive Airway Pressure 2 salicylsalicylic acid 1 penclomedine 1 licogliflozin 1 follitropin beta 1 elagolix 1 drospirenone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01185704 2014-02-13

ATTAC-PCO

Merck KGaA, Darmstadt, Germany

Phase 3 Completed

136 enrolled 21 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡